TrialBlood2013

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.

Jason A Dubovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.